article thumbnail

#news #biotech PCR-test reveals risk of genotoxity of genome editing

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: PCR-test reveals risk of genotoxity of genome editing. from European Biotechnology – first and foremost in European biotech [link].

article thumbnail

Genotox Laboratories Announces Availability of 1,500 COVID-19 Tests per Day

BioTech 365

Number of Tests Accepted per Day is Limited to Ensure Rapid Turnaround Time AUSTIN, Texas–(BUSINESS WIRE)–#coronavirus–Genotox Laboratories, an Austin, Texas based company, has announced the capacity to complete 1,500 COVID-19 tests per day.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A bioresorbable membrane for healing internal and external wounds

Medical Xpress

Fraunhofer researchers have succeeded in using the bioresorbable silica gel Renacer to produce an electrospun membrane that is neither cytotoxic to cells nor genotoxic. This model mimics fibrous structures found in connective tissue and is therefore particularly suitable for regenerative applications, such as for improved wound healing.

article thumbnail

ICH announces sign-off of residual solvent guideline

The Pharma Data

According to a Step 4 training presentation on the guideline, the Q3C (R8) Expert Working Group (EWG) review of available toxicity data with 2-MTHF, also known as tert -butylmethyl ether, found no evidence for genotoxicity or reproductive toxicity and no observed effect level in repeat dose toxicity studies involving rats.

article thumbnail

Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities

Roots Analysis

Genotoxicity testing refers to the evaluation of detrimental effects of chemical or physical agents on the genetic processes and related hereditary material of living cells. Mechanism of Genotoxicity / Mutagenicity The interaction of genotoxins / mutagens with the structure of DNA causes damage to the genetic material.

article thumbnail

Expert consortium comment on FDA report on risk of T-cell malignancy  

Drug Discovery World

These therapies, which exhibit substantial long-term side effects, including genotoxicity and an increased predisposition to secondary cancers, have significantly higher rates of subsequent malignancies than the rate reported for patients following CAR-T cell immunotherapies.

article thumbnail

The Composition and Value of a Portfolio Analysis


A nonclinical safety evaluation program typically includes pharmacology, general toxicity, toxicokinetics, nonclinical PK, reproductive toxicity, genotoxicity, and carcinogenesis. Nonclinical Requirements. Chemistry, Manufacturing, and Controls (CMC) Strategies.